A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2018
Price : $35 *
At a glance
- Drugs Glycopyrrolate (Primary) ; Aclidinium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms GOLDEN-6
- Sponsors Sunovion Respiratory Development
- 24 May 2017 Results from GOLDEN 2 and GOLDEN 6 trials presented at the 113th International Conference of the American Thoracic Society
- 15 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.